Changchun Bcht Biotechnology Co.

This early-stage trial tests a new flu vaccine that includes an adjuvant called BK-01, designed to boost the immune response. About 160 adults aged 18 and older will receive either the new vaccine, a standard flu vaccine, or a placebo. Researchers will monitor for side effects an…

This early-stage trial is testing a new combination vaccine that protects against whooping cough, diphtheria, and tetanus (Tdap) in people aged 10 and older. Researchers want to see if different doses are safe and trigger an immune response. The study involves 96 volunteers and c…